PROBE-PD
  • Sobre
  • Projeto
  • Equipe
  • Publicações
  • Parkinson
  • Contato
  • Português
    • Português
  • Home
Escolha uma Página

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.

por jcdadm.website | mar 13, 2018 | Publication

Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurology. 2018 Mar 13;90(11):e932-e939. doi: 10.1212/WNL.0000000000005120. Epub...

CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.

por jcdadm.website | jan 30, 2018 | Publication

Benedet AL, Yu L, Labbe A, Mathotaarachchi S, Pascoal TA, Shin M, Kang MS, Gauthier S, Rouleau GA, Poirier J, Bennett DA, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurol Genet. 2018 Jan 30;4(1):e216. doi: 10.1212/NXG.0000000000000216....

Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.

por jcdadm.website | jan 1, 2018 | Publication

Gauthier S, Ng KP, Pascoal TA, Zhang H, Rosa-Neto P. J Alzheimers Dis. 2018;64(s1):S23-S31. doi: 10.3233/JAD-179924.

Identifying incipient dementia individuals using machine learning and amyloid imaging.

por jcdadm.website | nov 1, 2017 | Publication

Mathotaarachchi S, Pascoal TA, Shin M, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Neurobiol Aging. 2017 Nov;59:80-90. doi: 10.1016/j.neurobiolaging.2017.06.027. Epub 2017 Jul 11.

Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.

por jcdadm.website | out 31, 2017 | Publication

Gauthier S, Ng KP, Pascoal TA, Mathotaarachchi S, Chung CO, Benedetti AL, Shin M, Kang MS, Li X, Ba M, Kandiah N, Rosa-Neto P. Neurology. 2017 Oct 31;89(18):1931. doi: 10.1212/WNL.0000000000004593.

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly.

por jcdadm.website | set 5, 2017 | Publication

Li X, Ba M, Ng KP, Mathotaarachchi S, Pascoal TA, Rosa-Neto P, Gauthier S. Alzheimers Dement (Amst). 2017 Sep 5;10:12-21. doi: 10.1016/j.dadm.2017.08.001. eCollection 2018.
Página 12 de 14« First«...1011121314»

Recent Posts

  • Genetic risk of ADHD may boost odds of Alzheimer’s in old age
  • Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults
  • Molecular Psychiatry: Astrocyte Biomarker Signatures of Amyloid-β and Tau Pathologies in Alzheimer’s Disease
  • Pitt Psychiatry Awarded $33.5M NIH Program Project Grant Focused on the Pathological and Clinical Progression of AD
  • Study Challenges Dogma Behind Alzheimer’s Disease Drug Trials

Website by